These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24531073)

  • 1. Retraction: Designer bacteria degrades toxin.
    Nat Chem Biol; 2014 Mar; 10(3):239. PubMed ID: 24531073
    [No Abstract]   [Full Text] [Related]  

  • 2. Designer bacteria degrades toxin.
    Kirby JR
    Nat Chem Biol; 2010 Jun; 6(6):398-9. PubMed ID: 20479747
    [No Abstract]   [Full Text] [Related]  

  • 3. Botulinum toxin type a for dysthyroid upper eyelid retraction.
    Morgenstern KE; Evanchan J; Foster JA; Cahill KV; Burns JA; Holck DE; Perry JD; Wulc AE
    Ophthalmic Plast Reconstr Surg; 2004 May; 20(3):181-5. PubMed ID: 15167723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction. Designer DNA architectures for nanobiotechnology.
    Nucleic Acids Symp Ser (Oxf); 2008; (52):93-4. PubMed ID: 18776269
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin a (Botox) for relieving penile retraction.
    Shaeer O; Shaeer K; Shaeer A
    J Sex Med; 2009 Oct; 6(10):2788-94. PubMed ID: 19686423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of upper eyelid retraction associated with dysthyroid orbitopathy during the acute inflammatory phase with botulinum toxin type A].
    Nava Castañeda A; Tovilla Canales JL; Garnica Hayashi L; Velasco Y Levy A
    J Fr Ophtalmol; 2017 Apr; 40(4):279-284. PubMed ID: 28336282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A synthetic biology approach for evaluating the functional contribution of designer cellulosome components to deconstruction of cellulosic substrates.
    Vazana Y; Barak Y; Unger T; Peleg Y; Shamshoum M; Ben-Yehezkel T; Mazor Y; Shapiro E; Lamed R; Bayer EA
    Biotechnol Biofuels; 2013 Dec; 6(1):182. PubMed ID: 24341331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assembly of xylanases into designer cellulosomes promotes efficient hydrolysis of the xylan component of a natural recalcitrant cellulosic substrate.
    Moraïs S; Barak Y; Hadar Y; Wilson DB; Shoham Y; Lamed R; Bayer EA
    mBio; 2011; 2(6):. PubMed ID: 22086489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Vibrio cholerae Minor Pilin TcpB Initiates Assembly and Retraction of the Toxin-Coregulated Pilus.
    Ng D; Harn T; Altindal T; Kolappan S; Marles JM; Lala R; Spielman I; Gao Y; Hauke CA; Kovacikova G; Verjee Z; Taylor RK; Biais N; Craig L
    PLoS Pathog; 2016 Dec; 12(12):e1006109. PubMed ID: 27992883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deconstruction of lignocellulose into soluble sugars by native and designer cellulosomes.
    Moraïs S; Morag E; Barak Y; Goldman D; Hadar Y; Lamed R; Shoham Y; Wilson DB; Bayer EA
    mBio; 2012 Dec; 3(6):. PubMed ID: 23232718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin treatment for upper lid retraction of dysthyroidism.
    Chuenkongkaew W
    J Med Assoc Thai; 2003 Nov; 86(11):1051-4. PubMed ID: 14696787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Vector Force Model of Upper Eyelid Position in the Setting of a Trabeculectomy Bleb.
    Clark TJ; Rao K; Quinn CD; Batlle JF; Alward WL; Wester ST; Shriver EM
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):127-32. PubMed ID: 25794022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Botulinum toxin injection-treatment of upper lid retraction in thyroid eye disease].
    Dintelmann T; Sold J; Grehn F
    Ophthalmologe; 2005 Mar; 102(3):247-50. PubMed ID: 15322802
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designer Drugs and the Impact on the Adolescent User.
    Lavelle S
    Arch Psychiatr Nurs; 2016 Jun; 30(3):447-8. PubMed ID: 27256955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calyculin A-induced neurite retraction is critically dependent on actomyosin activation but not on polymerization state of microtubules.
    Inutsuka A; Goda M; Fujiyoshi Y
    Biochem Biophys Res Commun; 2009 Dec; 390(4):1160-6. PubMed ID: 19857460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and survey in cattle of a rumen Pyrimadobacter sp. which degrades the plant toxin fluoroacetate.
    Kang S; Khan S; Webb R; Denman S; McSweeney C
    FEMS Microbiol Ecol; 2020 Jul; 96(7):. PubMed ID: 32353874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulating toxin-antitoxin expression: controlled detonation of intracellular molecular timebombs.
    Hayes F; Kędzierska B
    Toxins (Basel); 2014 Jan; 6(1):337-58. PubMed ID: 24434949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection.
    Uddin JM; Davies PD
    Ophthalmology; 2002 Jun; 109(6):1183-7. PubMed ID: 12045064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A treatment of overactive corrugator supercilii in thyroid eye disease.
    Olver JM
    Br J Ophthalmol; 1998 May; 82(5):528-33. PubMed ID: 9713061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in the detection of designer steroids in anti-doping.
    Abushareeda W; Fragkaki A; Vonaparti A; Angelis Y; Tsivou M; Saad K; Kraiem S; Lyris E; Alsayrafi M; Georgakopoulos C
    Bioanalysis; 2014 Mar; 6(6):881-96. PubMed ID: 24702116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.